San Diego, CA, United States of America

Roy Kerckhoffs

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of California. Active years: 2024.


% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roy Kerckhoffs: Innovator in Cardiac Diagnostics

Introduction

Roy Kerckhoffs is a notable inventor based in San Diego, California. He has made significant contributions to the field of cardiac health through his innovative work in diagnosing heart failure. His research focuses on patient-specific modeling to predict outcomes of cardiac resynchronization therapy.

Latest Patents

Kerckhoffs holds a patent for "Compositions, devices and methods for diagnosing heart failure and for patient-specific modeling to predict outcomes of cardiac resynchronization therapy." This patent includes various compositions, medical devices, and methods for predicting the response of patients with dyssynchronous heart failure to cardiac resynchronization therapy. The invention involves measuring the fraction of the left ventricle/septum performing negative work and the coefficient of variation of external work density, which are correlated with observed reductions in end-systolic volume after therapy.

Career Highlights

Kerckhoffs is affiliated with the University of California, where he continues to advance research in cardiac diagnostics. His work has the potential to significantly improve patient outcomes in heart failure treatment.

Collaborations

He has collaborated with notable colleagues such as Andrew D McCulloch and Adarsh Krishnamurthy, contributing to the advancement of cardiac health technologies.

Conclusion

Roy Kerckhoffs is a pioneering inventor whose work in cardiac diagnostics is making a meaningful impact in the medical field. His innovative approaches are paving the way for improved therapies and patient care in heart failure management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…